z-logo
open-access-imgOpen Access
Helminth-induced immune response: A new perspective for the treatment of Multiple Sclerosis
Author(s) -
Karla Viana Rezende,
Ayrton Senna do Brasil Amaral Alves,
Juliana Carollyne Amorim,
Maria Inês Vaz de Oliveira,
Maria Paula Banhara Rodrigues,
Vitor Matias Grah
Publication year - 2021
Language(s) - English
Resource type - Conference proceedings
DOI - 10.5327/1516-3180.603
Subject(s) - context (archaeology) , immune system , multiple sclerosis , disease , immunology , medicine , perspective (graphical) , biology , pathology , computer science , paleontology , artificial intelligence
Background: Multiple Sclerole (MS) is a progressive neurodegenerative disease that, in its most common form, evolves in outbreaks and compromises the patient’s quality of life and functionality. In a long time, a way of attenuating symptoms and preventing the progression of this pathology has been studied, however, drug therapies, until now, have not shown good accuracy. In this context, the exogenous use of helminths as non-drug therapy for MS has been considered, therefore, this study aims to demonstrate the recent results of studies on such therapies and verify whether there is scientific evidence of a good clinical, immunological and exam response. image of patients with MS. Methods: Bibliographic review in the PUBMED database Results: The four large studies carried out on the topic demonstrated evidence that the immune response induced by helminths decreases the activity of the immunological factors that contribute to the progression of MS, however the small control groups and unfavorable environments impaired the conclusions of the studies . Conclusions: Although the studies have no yet to demonstrate reliable clinical evidence about exogenous helminth therapy, it is undeniable that the good immune response induced by the parasites is a great hope that motivates the continuation of studies in the area.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here